2023 FTC 'Heart·Treasures': Call for Rare Cardiovascular Surgical Case Submissions
The heart is the “engine” of the human body and one of its most vital organs. Once this engine ceases to function, it can lead to systemic failure or even complete collapse. How to maintain normal cardiac function, and how to repair or even replace the heart through surgical interventions, remain areas of ongoing exploration and research.
Humanity continually advances through breakthroughs and innovation, and the field of cardiac surgery is no exception. Cardiovascular specialists, guided by a spirit of exploration and continuous learning, have risen to challenges and driven repeated breakthroughs and innovations in the field of heart and great vessel diseases. Aortic aneurysms, once incurable, are now routinely treated with standard surgical procedures. It is precisely this pioneering spirit of exploration—from nothing to something—that has propelled the development of cardiovascular medicine to its current state.
To collect more cases of rare surgical treatments related to the heart and great vessels, organize expert teams for in-depth discussions, better share and disseminate diagnostic and treatment experiences, further enhance the clinical capabilities of physicians, ensure that more patients receive correct diagnosis and treatment, and promote further development in the field of cardiac and great vessel diseases, the Cardiovascular Technology and Engineering Branch of the China Biopharmaceutical Technology Association, Peking Union Medical College Hospital, and the First Affiliated Hospital of the University of Science and Technology of China (Anhui Provincial Hospital) have jointly initiated this effort.Call for Case Studies on Rare Cardiac Surgical ProceduresWe are soliciting rare cardiovascular surgical case reports from specialists in cardiology and cardiac surgery, radiologists, and sonographers across China. Each rare surgical case deserves meticulous documentation and sharing; these are precious clinical achievements that stand as milestones in clinical medicine and serve as beacons guiding more patients toward appropriate medical care.
Recruitment Period: November 1–November 18
Evaluation Period: November 18–November 24
Public Notice Period for the Project: November 27–November 29
Online Exhibition Period: December 2
Target Population:Call for Cardiovascular Rare Surgical Cases from Specialists in Cardiac and Great Vessel Surgery, Radiology, and Ultrasound Across China
Case Submission:Actual surgical video footage covering all procedure types performed by the Department of Cardiovascular Surgery, including but not limited to interdisciplinary treatments for Behçet's disease-associated congenital heart disease, coronary artery disease, valvular heart disease, cardiomyopathy, aortic diseases, pericardial diseases, and pathologies involving the primary branches of the aorta and pulmonary vasculature.
Recommended video format:MP4 format, with a resolution of no less than 720P, a duration not exceeding 30 minutes, narration provided for key procedures, minimal camera shake, and authorization granted to the conference organizing committee for public display.
Selected outstanding cases will be invited to deliver specialized academic presentations at the 2023 FTC.
Complimentary admission to the 13th Pangu Great Vessel Disease Forum (2024), a Certificate of Inclusion in the Pangu Rare Case Museum, and tangible rewards.
Scan the QR code or click the link to register.http://yomejodovblbj4mj.mikecrm.com/fg8NW42
Call for Submissions Inquiry: Ms. Gao / 15101001172
FTC Event Inquiry: Ms. Dong / 15330701571
About the 5th FTC Frontier Technology Forum in Cardiac Surgery (2023)
The 5th Frontier Technologies in Cardiac Surgery Forum (FTC 2023) was co-hosted by the Cardiac Surgery Technology and Engineering Committee of the China Medical Biotechnology Association and Peking Union Medical College Hospital, with co-organization by the First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital). The forum aimed to bring together experts, scholars, corporate representatives, and industry professionals from home and abroad in the field of cardiac surgery to jointly discuss technological advancements and development trends, industrial innovation, and collaborative opportunities. ExcellentRare Disease Surgical Case StudiesOnline presentations and exchanges will be conducted, with relevant experts and scholars invited to participate in order to promote the sharing of technology and experience.
About the Pangu Aortic Disease Forum
The Pangu Great Vessel Disease Forum, established in 2009, aims to popularize knowledge related to the diagnosis and treatment of great vessel diseases and strengthen the application of new diagnostic and therapeutic techniques. After 12 editions, the "Pangu Great Vessel Disease Forum" has become a brand academic conference on great vessel diseases that is aligned with international standards. Centered on academic exchange, the forum explores international trends in diagnosis and treatment and focuses on key academic topics in China. By continuously summarizing clinical and basic research achievements and new technologies in the field of great vessels both domestically and internationally, it features sub-forums covering various subspecialties, including surgery, interventional therapy, anesthesiology, extracorporeal circulation and life support, critical care medicine, medical imaging and ultrasonic diagnosis, and nursing, thereby promoting academic exchange and sharing among professionals in disciplines related to great vessel surgery.
About the 2023 Future Medical Technology Conference
From November 30 to December 1, 2023, the 2023 Future Healthcare Technology Conference will be held in Hefei. The conference will systematically review the 30 most noteworthy cutting-edge technologies in the life and health sector, inviting research scholars aligned with these technological trends to share insights on forward-looking technical developments. It aims to create a technological feast featuring the release of frontier technologies, the exhibition of innovative tech products, and ecosystem collaboration among healthcare technology enterprises. Having been successfully held for three previous editions, this year’s conference is expected to attract over 100 influential figures in technology, 100 tech companies, and 800 professional attendees. As one of the concurrent events of the Future Healthcare Technology Conference, the 2023 FTC 5th Frontier Technology Forum in Cardiac Surgery will also garner significant attention from various sectors.